News

28.05.2026

GBAICTI Welcomes Danish Health and Life Sciences Delegation

The Greater Bay Area International Clinical Trial Institute (GBAICTI) was pleased to host a delegation from the Royal Danish Consulate General in Guangzhou for a site visit to the Hetao area.

Arrow right View More

13.05.2026

Showcasing Hong Kong’s Clinical Trial Strengths at Asia Summit on Global Health 2026

The Greater Bay Area International Clinical Trial Institute (GBAICTI) participated in the Asia Summit on Global Health held from 11–12 May 2026, joining global healthcare leaders and industry stakeholders to exchange insights and explore opportunities for collaboration in advancing innovation across the life sciences sector.

Arrow right View More

05.05.2026

Accelerating Clinical Trials Together: CRO Partners Connect

The Greater Bay Area International Clinical Trial Institute (GBAICTI) held our inaugural Hong Kong CRO Partners Connect this week, bringing together 10 leading CROs to exchange views on strengthening Hong Kong’s clinical trial ecosystem.

Arrow right View More

24.04.2026

Shaping the Future of Clinical Excellence in Hong Kong: Investigator Site Training Survey

As part of GBAICTI's mission to provide one-stop support for clinical trials and develop regional talent, we are establishing the International Clinical Trial Academy (ICTA). 

We are inviting you to take 10-15 minutes for this survey to help us design trainings that best suit the industry's needs.

Arrow right View More

15.04.2026

GBAICTI Hosts Seminar on Hong Kong Drug Registration Landscape

The Greater Bay Area International Clinical Trial Institute (GBAICTI) held a seminar on the Hong Kong drug registration landscape on 15 April 2026, bringing together industry stakeholders for an engaging exchange of insights on regulatory developments and clinical trial advancement in Hong Kong and the Greater Bay Area (GBA).

Arrow right View More

29.01.2026

Driving Real‑World Research Forward to Empower Healthcare Innovation Across the GBA

2026 GBA Real-World Research and Application Forum Ends on a High Note

Arrow right View More